The AACR 2026 TPD Post-Conference Report

The AACR 2026 Annual Meeting marked another milestone year for Targeted Protein Degradation (TPD), with a record number of abstracts and newly disclosed assets underscoring the modality’s continued momentum.

Our Post‑Conference Report brings together all the TPD-related findings into one clear PDF. Designed to save you time, this report gives you a complete view of how the TPD landscape is evolving across modalities, targets and development stages.

Get the Full TPD Readout from AACR

From thousands of presentations at AACR 2026, our analysts identified 188 TPD‑relevant abstracts, an 18% increase compared with 2025, and the highest total to date!

We’ve translated this growing volume of data into clear, decision‑ready insight, structuring it so you can quickly understand where activity is concentrating and what’s changing.

The report includes:

  • 188 TPD‑relevant abstracts analyzed, including 17 clinical and 171 preclinical studies
  • A clear breakdown of TPD activity by therapeutic class, from molecular glues and PROTACs to emerging modalities
  • 43 newly disclosed TPD drugs, highlighting sustained innovation across the field
  • Concise summaries of every abstract, with direct links for fast, targeted follow‑up
AACR 2026 TPD Post-Conference Report

You May Also Be Interested In…

Learn More About TPD

What is Beacon TPD?
  • The Most Comprehensive Way to Search the TPD Drug Development Landscape: Unique search ontologies based on TPD drug and trial characteristics
  • Market Leading Approach to TPD Preclinical & Clinical Data Curation: Manual curation of key TPD research and development data points by TPD research scientists
  • Seamlessly Integrate Commercial & Scientific Data all in One Place: Search TPD company and deal data based on their pipeline and technologies.
  • Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
Learn More About Beacon TPD Request Demo

What is Beacon?

Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.

Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.

This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.

We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!

Request Demonstration

Menu
Search Icon
Close Icon
Search